illofaciallmplants, and the International Journal of Periodontics & Restorative Dentistry and the bibliographies
of all relevant papers and review articles. In addition, researchers, journal editors, and industry sources were contacted to see if pertinent unpublished data that had been accepted for publication were available.
Selection Criteria Inclusion criteria: Human studies with a minimum of 20 interventions, a minimum follow-up period of 1-year loading, an outcome measurement of implant survival, and published in English, regardless of the evidence level, were considered.
Exclusion criteria: Studies involving multiple simultaneous interventions (e.g., simultaneous ridge augmentation) and studies with missing data that could not be supplied by the study authors were excluded.
Data Collection and Analysis: Where adequate data were available, subgroups of dissimilar interventions (e.g., surgical techniques, graft materials, implant surfaces, membranes) were isolated and subjected to metaregression, a form of meta-analysis. Main Results
1.
Forty-three studies, 3 randomized controlled clinical trials (RCTs}, 5 controlled trials (CTs}, 12 case series (CS), and 23 retrospective analyses (RA) were identified. Thirty-four were lateral window interventions, 5 were osteotome interventions, 2 were localized management of the sinus floor, and 2 involved the crestal core technique. 2. Meta-regression was performed to determine the effect of the variables of block versus particulate grafting techniques, implant surface, graft material, and the use of a membrane over the lateral window.
3. The survival rate of implants placed in sinuses augmented with the lateral window technique varied between 61.7% and 1 00%, with an average survival rate of 91.8%.
For lateral window technique: 4. Implant survival rates reported in this systematic review compare favorably to reported survival rates for implants placed in the non-grafted posterior maxilla.
5. Rough-surfaced implants have a higher survival rate than machine-surfaced implants when placed in grafted sinuses.
6. Implants placed in sinuses augmented with particulate grafts show a higher survival rate than those placed in sinuses augmented with block grafts.
7. Implant survival rates were higher when a membrane was placed over the lateral window. 8. The utilization of grafts consisting of 100% autogenous bone or the inclusion of autogenous bone as a component of a composite graft did not affect implant survival. 9 . There was no statistical difference between the covariates of simultaneous versus delayed implant placement, types of rough-surfaced implants, length of follow-up, year of publication, and the evidence level of the study.
Reviewers' Conclusions: Insufficient data were present to statistically evaluate the effects of smoking, residual crestal bone height, screw versus press-fit implant design, or the effect of implant surface micromorphology other than machined versus rough surfaces.
There are insufficient data to recommend the use of platelet-rich plasma in sinus graft surgery.
Ann Periodontol 2003;8:328-343.

KEYWORDS
I nadequate alveolar bone height is a common limitati~n in the _placement o_f endosseous root-form dental1mplants m the postenor maxilla. Grafting the floor of the maxillary sinus has emerged as the most common surgical modality for correcting this inadequacy. This technique, first published in 1980 by Boyne and James 1 and subsequently modified by other clinicians, 2 · 1 0 can result in an increase in bone height that allows the placement of implants of conventional length in the grafted sites.
In addition to the various techniques utilized to elevate the sinus floor, there are many variables that may alter the outcome of this procedure. Among them are simultaneous versus delayed implant placement; the use of a barrier membrane over the lateral window; the use of various grafting materials; and the utilization of implants with varying surface characteristics, lengths, and widths. Further, the effects of smoking and residual crestal bone height may also influence outcomes.
The goal of this review was to assess the efficacy of the sinus augmentation procedure by systematically reviewing the available literature.
RATIONALE
The goal of this review was to assess the efficacy of the sinus augmentation procedure by systematically reviewing the available literature. As part of the review process, researchers were contacted when possible to fill in missing data or clarify ambiguous data in previously published reports. Known researchers, journal editors, and industry sources were contacted to determine if pertinent unpublished data that had been accepted for publication were available. All search strategies were updated to extend the cut-off date to April 1 , 2003 . Both the titles and abstracts from the search were independently screened for inclusion by the review authors. The full text of all studies of possible relevance were obtained and independently reviewed by the review authors (SSW, SJF). Disagreements at each level of the review process were resolved by discussion.
FOCUSED QUESTION
Inclusion criteria: All studies involving the placement of root-form screw or cylinder implants in augmented maxillary sinuses were considered. An outcome measure of implant success or implant survival had to be reported. As the number of randomized controlled clinical trials (RCTs) was found to be limited, all levels of evidence including controlled trials (CT), case series (CS), and retrospective analyses (RA) were selected for further evaluation by the inclusion criteria.
The original inclusion criteria for this review were as follows: 1) human, English language publications; 2) minimum of 20 interventions (i.e., lateral window sinus augmentations or osteotome elevations); 3) outcome measure of implant success or implant survival reported; 4) absence of multiple interventions (e.g., simultaneous ridge augmentations); 5) minimum of 1-year loaded follow-up (or a range that exceeds 1 year); and 6) a dropout/withdrawal rate of =:;5%.
Exclusion criteria: Studies involving multiple interventions (e.g., simultaneous ridge augmentation) and stud ies with missing d ata that could not be su p plied by the study authors were excluded.
Ranking of Studies Study q uality was independently assessed by th e reviewers and the studies grou ped by general ca tegor y (RCT, CT, CS, and RA).
Data Collection and Analy sis Multiple confounding relationships m ay result in significant differences in the outcome m easurement of implant 330 survival. Where adequate data ex isted, subgroups of dissimilar interventions (e.g., surgical technique, graft material) were isolated and subjected to meta-regression, a form of meta-analysis, to identify them as possible sources of covariance.
Data sheets were prepared to extract all data of possible relevance for statistical analysis of study variables. The extraction was performed independently by both reviewers to insure accuracy. Missing data were filled in , when possibl e, by correspondence w ith the study authors.
MAIN RESULTS
Methodological Quality
Overall study quality was deemed poor, with RCTs and CTs accounting for only 18.6% of the included studies (8 o f 43). W ith modification of the inc lusion c riteria ag reed upon ea rl y in the process, initial agreement between the reviewers was h igh with all disagreements resolved after discussion (6 studies) or the procurement of additional data from the study authors (6 studies). Ra ting of the included studies by defined c riteria such as those of J adad et al. 1 1 based upon criteri a including ra ndomization, m asking , and withdrawals (loss to followup) wa s not practica l. S ince loss to f o llow-up was unrecorded or unclear in 18 of the 43 studies (41.9%), this requirem ent was eliminated from the inclusion criteria of this review. Thirty-two out of the 43 studies (74.4%) used implant survival as the primary outcom e m easure. Among those that repor ted implant success, the c rit eria for success varied greatly. Therefore, implant surv ival ( i.e., implant rem ains in fun ction , no pain or mobility, no radiographic evidence of infection) was chosen as the default outcom e, even if both values were given. Furthermore, in many studies imp lant su rv ival was not reported for a standard time interval , but was reported as a range. This was accepted, with a minimum of 12 m onths of loading considered for inclusion in this review.
Data Extraction
The sea rc h strategy revea led 893 (858 electron ic search , 35 man ua l search ) articles of p ossible relevance . One hundred and fifty-six ( 156) of these articles were eva luated in full -text version and 43 met the m odified inclusion c riteria. Of these , 34 12 -45 uti lized latera l window inter ventio ns, 5 utilized th e osteotom e techn ique, 46 -50 2 utilized localized managem ent o f the sinus floor (LMSF), 51 • 52 and 2 utilized crestal core elevation techniques. 53 • 54 The number of qualifyi ng studies of each study design (RCT, CT, CS, or RA) for ea ch of the 4 interventions (lateral w indow, osteotome, localized management of the sinus fl oor, and crestal core elevati on ) are shown in Tables 2 th rough 5. The combi ned ra w implant data for each interventio n, and the overall combined implant data are listed in Table 6 . Abbreviations: auto = autogenous; allog = allograft; BPBM = bovine porous bone mineral; BMP = bone morphogenetic proteins; DFDBA = demineralized freezedried bone allograft; DLB = demineralized laminar bone; ePTFE = expanded polytetrafluoroethylene; HA = hydroxyapatite; por coli = porcine collagen; PRP = platelet-rich plasma; TCP = tricalcium phosphate; TPS = titanium-sprayed surface. The following 3 factors were found to be related to implant survival: 1) machined implants versus rough implants (84.0% and 91.6%, respectively) {Table 7); 2) iliac block grafts versus particulate grafts (83.3% and 92.3%, respectively) ( Table 8) ; the above-mentioned effects with the appropriate interaction between the 2 were modeled along with the covariates of year published and the length of followup {Table 9); 3) membrane versus no membrane over lateral window (93.6% and 88.7%, respectively). Table 10 identifies 3 studies 13 • 15 • 16 that directly compared implant survival following use or non-use of a membrane. In each of the 3 studies, implant survival was significantly higher when a membrane was utilized. Figure 1 presents a meta -analysis of the data from the 3 above-mentioned studies. Table 11 gives implant survival statistics for all studies utilizing particulate grafting techniques with (5 studies) and without ( 15 studies) a membrane over the lateral window.
Summary of Data from Osteotome Sinus Augmentation Studies
Summary of Data from Localized Management of Sinus Floor Studies
As can be seen in These data were subjected to meta-regression, a form of meta-analysis, to answer the primary question relating to overall implant survival. Secondary questions relating to various surgical tec hniques, grafting materials, and implant surfaces were also subjected to comparison by m eta-regression to determine if these potentially confounding relationships resulted in significant statistical differences.
Methodological Quality Any discussion of the data presented in this systematic review must be preceded by a discussion of the methodological quality of the studies that comprise the data for the review. Study quality was deemed poor. 
Effect o( the use o( a barrier membrane.
Wallace, Froum grafted posterior maxilla, would be difficult to conduct and to date data of this kind do no t exist. For this reason intra -study comparisons o f implant placements in grafted sinuses to implan ts p laced in th e nongrafted posterior maxilla were not possible. Furthermore, there is a pauc ity of published data reporting on aborted or fa iled sinus grafting procedures that precluded implant placement. This would not result in a change in the implant survival rate of placed implants, but it must be accounted for in a com parison of patient outcomes. The effectiveness of meta-analysis is dependent not only upon the quality of the included studies, but their similarity. Meta-analysis generally involves studies that are comparative in nature and is strongest when the level of evidence includes high quality RCTs. Ev aluation of data from multiple studies that are one-group designs requires meta-regression. Dissimilar inter-ventions (surgical techniques) , variable graft m aturation and osseointegration times, varying follow-up times, differing criteria for success, the utilization of multiple grafting materials, and diverse implant macro-and m icromorphologies can effect the validity o f the analysis. For that reason, the present review attempted to isolate som e of the significant variables to determin e their effect on the overall database. Metaregression evaluates the many covariates that exist between studies to try to insure that differences in results are, in fact, real effects. 55 In 1998 Jensen et al. 56 published the data from the Academ y of Osseointegration Sinus Consensus Conference of 1996. This report included a m eta -analysis of the data collected from 38 surgeons who performed 1,007 sinus grafts wi th 2 ,997 implants placed and followed for a minimum of 3 years. The overall survival rate was reported as 90%. This report is not included in the present review as it contains data from both published and unpublished sources. Furthermore, the data from that conference would represent a duplicati on of some of the studies inc luded in this review.
Prev ious evidence-based reviews o f the maxillary sinus augmentation procedure have been published by Tolman 57 and Tong et al. 58 Tolman 57 dures in the mandible and maxilla. Inclusion c riteria were not specifically stated. Included studies were those that were clinically related with data on implants placed in grafted bone. Overall sur viva l rates for im plants placed in grafted sinuses were reported as 9 1% for implants placed in block grafts and 94% for implants placed in particulate grafts. Survival rates were lower for delayed placements than for immediate placem ents in both the block graft group (84% and 92%, respectively) and the particulate graft group (9 1% and 100%, respectively). A disproportionate number of the failures in the delayed particulate group (301 implants) involved a small number of m achined implants ( 12 of 35 impl ants). In the delayed block graft group (6 1 implants), a small number of TPS cylinder implants accounted for the higher failure rate (8 of 24 implants). Tong et al. 58 selected 10 of 28 identified articles for inclusion in their meta -analysis. Inclusion criteria were 1) at least 10 patients; 2) all patients received root-form endosseous implants; 3) less than 5% of patients were lost to follow-up over a 6-month period; 4) patient follow-up was no less than 6 months; and 5) data regarding survival of implants were reported. The overall survival rate for the 1,096 implants included was 93%. 5 8 as susceptible to publication bias as the more recent studies. As techniques become m ore universally applied, the overall quality of stud ies tends to improve.
The present review reports on 3,354 interventions and 6,443 placed implants with an overall survival rate of 92.6%. In studies that utilized only the latera l w indow technique, the reported surviva l rate for 2,178 inter ventio ns with 5 ,267 impla nts placed was 91 .8%. The database for this review is larger than that of the 3 previously mentioned reviews combined 56 · 58 and somewhat smaller than the Del Fabbro et al. review 59 w ith regard to lateral window placements. This reflects the recent increase in studies relating to sinus grafting after the 1996 Academy of Osseointegration Sinus Consensus Conference concluded "The sinus graft should now be considered a highly predictable and effective therapeutic m odality. " 56 A lthough the large number of interventions included in this review may be the result of liberal inc lusion criteria that accepted respective studies, all the studies included for analysis do have the minimum 1-year loaded follow-up.
The surviva l rate for imp lants placed in g rafted sinuses compares favorably to those generally reported for implants placed in pristine bone in the no n-grafted posterior maxilla. 60 -67 Results from 8 studies that isolate success/ survival data for implant placement in the non-grafted posterior maxilla, adjusted to raw survival data , appear in Table 13 . The survival rate averaged 95 .1 %. Results of a 3-yea r Veterans Administration study reported a 97.5% survival rate for 120 implants placed in grafted sinuses compared to a 90.3% survival rate for 453 implants placed in the non-grafted posterior maxilla in a conventional manner. 6 4 It should be no ted that none of these studies presented a splitm outh random ly controlled methodology. The present review further identified 3 interventions th at were not incl uded in the 2 earlier reviews. The osteotom e technique (5 studies, 46 · 50 445 implants, and 93.5% survival}, localized management of the sinus floor (2 studies, 51 · 52 557 implants, 96.9% survival} and the cresta l core elevation/ex traction sock et techn ique (2 studies, 53 · 54 174 implants, 98.3% surviva l). While these results appear promising, the data are insufficient fo r statistical analysis.
Gra fting Mat erials
The Academy of Osseointegration Sinus Consensus Conference of 1996 approved autogenous bo ne as acceptable for sin us grafting , further stating that other grafting materials (i.e., allografts, xenografts, and alloplasts) may be acceptable, but required furth er eva luation.56 T hat eva luation has been for thcoming over the past 7 years.
The present review found that the block grafting techn ique result s in a statistica lly s ign ificant lower implant sur vival rate (83.3%) than do all particulate grafts combined (92.3%). T he lower sur vival ra te may be ind icative of a more demanding surgica l procedure whic h requires stabil ization of the block g raft as well as the implant, the tendency of the iliac block graft to resorb and the cova riable effect of the use of machinesurfaced implants in 6 o f the 7 block graft stu dies. 14·1 7·22·33·34·44 The review by Del Fabbro et al. 59 noted that 69.5% of all im plant s placed in 100% autogenous bone grafts had a mac hined surface. These of implants in iliac block grafts to delayed p lacement in autogenous particulate graft s. T he study inc luded 20 pa tients in each group and an almost ident ical number of imp lants (76 and 74, respectively). Survival rates fo r implants placed in the iliac blocks and the particu late g rafts were 78.9% and 89.2%, respectively. T he authors stated that the po pulation was too sma ll to ascribe sta tistical significance to the results; however, they noted that thei r preference is now the 2-stage procedure.
This review found no statistically significant difference in implant survival when comparing particulate autogenous bone w ith par ticulate bone replacement grafts. Froum et al. 16 demonstrated similar implant sur vival rates for a xenograft* when utilized with or without autogenous bone. Hising et al. 31 reported a higher implant surviva l rate in cases where a xenograftt was used as the sole graft material (92.2%) than when it was used as a composite with autogenous bone (77.2%). In a study by Hallman et al. 21 the implant survival rates for sinuses grafted with particulated ramus autograft, a 20/ 80 autogenous/xenograftt composite, and 100% xenograftt were 82.4%, 94.4%, and 96%, respectively.
A review assess ing the valu e of anorga nic bon e additives by Merkx et al. 68 reported that autogenous grafts had a higher percentage of vita l bone at 4 to 6 m onths than did anorganic bone replacem ent grafts. However, several histological studies !6. 2 3.69, 7 0 showed that similar percentages of vital bone can be achieved in bone replacem ent grafts and in g rafts with an autogenous component, provided the bone replacement grafts are allowed a longer maturation period. Further, Valentini et a1. 23 have reported that residual xenograft in a m aturing graft resides in the connective tissue compartment and, when combined with newly formed vital bone, can c reate a graft of exceptionall y high density (i. e., vital bone p lu s residual m in eralized xenograft). Histology of explants from the maxillary sinus do not show residual xenograft partic les in con-
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t Bio·Oss. OsteoHealth Co., Shirley, NY. tact with the implant surface, thereby leaving the implant surface free to interface with newly formed vital bone.7 1 • 72 Implant Surfaces Statistical differences were apparent when comparing machine-surfaced implants versus all other implant surfaces (i.e., rough or textured titanium surfaces, hydroxyapatite-coated surfaces) with unadjusted mean implant survival rates of 95.2% and 82.4% for rough and machined implants, respectively ( Table 7 ). The data on the effect of implant surface micromorphology on implant survival was evaluated in a covariance model with the type of grafting procedure. When this was done (Table 9 ), the survival rates of rough surfaced and machine-surfaced implants in particulate grafts become 94.6% and 90.0%, respectively. In iliac block grafts the survival rates for rough surfaced and machine-surfaced implants were 89.5% and 78.8%, respectively. Membranes A randomly controlled clinical trial by Tarnow et al., 1 3 in which the presence or absence of a barrier membrane was the only variable, reported implant survival rates of 100% and 92.6%, respectively, for grafts with and without membranes. A controlled trial by Tawil et al. 15 reported 93.1% survival in the membrane group and 78.1% in the no-membrane group. Another controlled trial by Froum et al. 16 reported 99.2 %survival in the membrane group and 96.3% when a membrane was not utilized {Table 10). A meta-analysis of these 3 comparative studies (Fig. 1) supports the hypothesis that membrane utilization is a useful adjunctive therapy that results in an increased survival rate (P <0.02) for implants placed in sinus grafts.
In a second analysis implant survival in 5 studies with particulate grafts that utilized a membrane over the lateral window was 93.6% for 919 implants, as compared to 88.7% for 2,436 implants in 15 studies that did not utilize a membrane (Table 11 ) . Again the survival rate for the studies utilizing a membrane (using each study as anN= 1) was significantly better (P<0.05) than for the studies that did not utilize a membrane. The strength of this analysis was increased by the similarity of the survival rates in both the direct comparisons (3 studies) 1 3· 15 · 16 and in the comparative case series (15 versus 5 studies; Table 11 ).
The increase in implant survival may be explained by the reported higher percentage of vital bone that results when a membrane is placed over the window. A bilateral RCT with the presence or absence of a membrane over the window being the only variable by Tarnow et al. 13 reported vital bone formation of 25.5% (SD 14.5) when a membrane was utilized and 11.9% (SD 7.9) when a membrane was not placed over the lateral window. Simultaneous Versus Delayed Implant Placement As presented in Table 2 for the lateral window technique, there are 12 studies with simultaneous placement, 9 studies with delayed placement, and 13 studies reporting on both techniques. Of those reporting on both techniques, 8 studies separated the data. The implant survival rates for the combined simultaneous placement and delayed placement studies (Table 12) were 89.7% and 89.6%, respectively.
In evaluating these data, one must consider the number of covariables that are present when implant survival data are combined in non-controlled studies. In this case covariables include, but are not limited to, block versus particulate surgery, machined versus rough surface, and presurgical residual crestal bone height. Residual crestal bone height in the included studies varied from 1 to ~8 mm. The ranges for simultaneous or delayed placements overlap, thus blending the 2 intervention types and their subsequent survival rates. Furthermore, not all studies listed the minimum or range of residual crestal bone heights included in the studies (28 of 34 reported). It is reasonable to consider that the failure rate for delayed implants is influenced by the fact that delayed placement is more likely to be utilized in cases that had lesser height of residual crestal bone as opposed to simultaneous placements that are most likely to have a greater height of residual crestal bone. It should be noted, however, that studies by Peleg et al. 26 • 36 have reported 100% implant survival in simultaneous placements with 1 to 2 and 3 to 5 mm of crestal bone.
The data available for this review were insufficient to draw statistical conclusions on the effect of residual crestal bone height on implant survival. While 28 of 34 studies reported residual crestal bone height to range from 1 to ~8 mm, none of the studies recorded the residual crestal height of failed implants.
Residual crestal bone height, as it relates to achieving primary implant stability, is a primary consideration utilized by the clinician in choosing a simultaneous over a delayed implant placement. Primary stability of implants has always been considered as an important factor affecting implant survival. Given similar bone quality, primary stability should be more easily achieved when a greater height of residual crestal bone is present. However, the significance of having a specific amount of residual bone height can be questioned. DePorter et al. 47 showed survival rates for short poroussurfaced implants similar to those reported for standard length implants. Testori et al. 66 • 67 clemonstrated· high success rates for short, acid-etched implants in poor quality bone, and Peleg et al. 26 reported 100% implant survival for simultaneous placement of hydroxyapatitecoated implants in sinus grafts with 1 to 2 mm of crestal bone. This situation highlights the difficulties encountered when attempting to draw conclusions from non-controlled studies due to the presence of multiple confounding variables. The above-mentioned studies all utilized textured or coated implants, while our original paradigms date back to the machine-surfaced implant.
In addition, one must consider the differences that may exist in the percent volume of vital bone available for osseointegration when comparing the residual crestal bone to a matured sinus bone graft. Ulm et al. 7 3 have reported that mean trabecular bone content by volume in the maxillary molar region may be as low as 6. 73% and averages 17.1% in females and 23.4% in males. Trisi and Rao 74 report trabecular bone volume of 28.28% ± 12.02% for bone quality of 04 (Misch classification). Histological studies by Froum et al. 16 and Valentini et al. 23 found vital bone volumes in this range for sinus bone replacement grafts. When this is considered in combination with the observation from sinus ex plants 71 • 72 that residual xenograft does not directly contact the implant surface, it could be speculated that osseointegration in these grafts is not hampered by the presence of the xenograft. In fact, the presence of the xenograft might provide additional structural stability to the matured graft that is lacking in grafts of pure autogenous bone and/or demineralized allograft. If this is correct, residual crestal bone height may only be important as it relates to initial mechanical primary stability, protecting the implant from micromovement resulting from inadvertent early loading.
Bone Morphogenetic Proteins and Bone Growth Factors
This review identified one rigorously conducted randomly controlled trial by Boyne et al. 12 that compared, with similar results, recombinant human bone morphogenetic bone (rhBMP-2)/collagen sponge implants to grafts of autogenous bone and composite grafts containing an autogenous component. A retrospective study by Rodriguez et al. 30 utilizing platelet-rich plasma (PRP) with no controls was also identified. This study reported an implant survival rate of 92.9%. This survival rate was lower than the average survival rate of 94.6% for the studies in this review that utilized particulate grafts and rough-surfaced implants without PRP. Histological reports by Froum et al. 75 and Wiltfang et al. 7 6 have shown only a 5 to 10% increase in vital bone formation when comparing sinus elevations using the same graft material with and without the addition of platelet-rich plasma. Zuffetti et al. 77 in an 8-case split-mouth sinus study utilizing cancellous iliac crest marrow, showed no significant differences in bone maturation level resulting from the use of PRP. A preliminary histomorphometric evaluation by Maiorana et al. 78 of 2 specimens utilizing 100% xenograft t plus PRP at 6 months postWallace, Froum grafting revealed a total bone percent volume (xenograft plus newly formed bone) of just below 40%. Valentini et al., 23 on the other hand, found a total bone percent volume of 60% for a 1:1 composite of demineralized freeze-dried bone allograft (DFDBA) and the same xenograft in a 6-month time period when utilized without PRP. Sanchez et al. 79 in a recent review concluded that there is a lack of evidence for the utilization of PRP in combination with bone grafts based on the existing studies of small sample size and poor quality, most of which have not shown highly positive outcomes.
REVIEWERS' CONCLUSIONS
Within the limits of this systematic review, the following conclusions can be drawn:
1. The survival rate of implants placed in augmented sinuses varied between 61.7% and 100% with the average survival rate of all interventions being 92.6%.
2. Implant survival rates reported in this systematic review compare favorably to reported survival rates for implants placed in the non-grafted posterior maxilla.
3. Rough-surfaced implants have a higher survival rate than machine-surfaced implants when placed in grafted sinuses.
4. Implants placed in sinuses augmented with particulate grafts show a higher survival rate than those placed in sinuses that had been augmented with block grafts.
5. Implant survival rates were higher when a membrane was placed over the lateral window.
6. The utilization of grafts consisting of 100% autogenous bone or the inclusion of autogenous bone as a component of a composite graft did not affect implant survival.
7. There was no statistical difference between the covariates of simultaneous versus delayed implant placement, types of rough-surfaced implants, length of follow-up, year of publication, and the evidence level of the study.
8. Insufficient data were present to statistically evaluate the effects of smoking, residual crestal bone height, screw versus press-fit implant design, or the effect of implant surface micromorphology other than machined versus rough surfaces.
9. Insufficient evidence exists to recommend the utilization of platelet-rich plasma in sinus graft surgery.
FUTURE DIRECTIONS
Further research is needed to determine the effect of residual crestal bone height and smoking on implant survival. Additionally, more data are required to determine the efficacy of bone morphogenetic proteins and bone growth factors on bone formation and implant survival in the maxillary sinus.
Controlled trials that limit the variables to the one that is being evaluated are required to properly identify and isolate the effects of what, to date, must be considered multiple confounding variables.
INTRODUCTION
This sinus bone augmentation Consensus Report represents a collaborative effort of all Section participants. The primary reviewer presented his data for each of the 5 questions. Section participants then expressed their concerns and suggestions which, in many cases, resulted in modifications to the consensus statements. The process was repeated until final consensus was achieved.
It was the consensus of all members of the Section that sufficient evidence was available to make the definitive statements presented in this report.
1. Does the Section agree that the evidence-based systematic review is complete and accurate? Yes. The Section members found that the reviewers were thorough and complete in assimilating a systematic review of evidence-based data for sinus bone augmentation. The following information should be noted.
While there was ample evidence to support the lateral wall approach for sinus bone augmentation, the studies on alternative techniques (e.g., osteotome, localized management of the sinus floor, crestal core elevation) for sinus bone augmentation are limited in number and no conclusions relating to implant survival rate can be drawn at this time.
2. Has any new information been generated or discovered since the evidence-based search cut-off date? Yes, 2 additional publications that provide supportive information have been identified:
A recent evidence-based review on the lateral wall approach for sinus bone augmentation by Del Fabbro et al. 1 determined an overall implant survival rate that was similar to that found with this review.
A recent study found no deleterious effects on voice quality and sinus physiology following sinus bone augmentation procedures. 2 3. Does the Section agree with the interpretations and conclusions of the reviewers? The Section participants found the interpretations and conclusions of the reviewers thorough and accurate. 4 . What further research needs to be done relative to the focused questions of the evidence-based review? The following studies were identified by the Section as areas for further research to individually evaluate the success of sinus bone augmentation and the success of implants placed in the augmented sinus.
Due to concerns regarding the limited data specifically evaluating the variable of residual crestal bone height, a research project is recommended for evaluating the success rate of implants as it relates specifically to minimal crestal bone height. These studies should ideally use a bilateral sinus model.
While no absolute contraindications exist in the literature, it would be beneficial to evaluate implant success as it relates to potential risk factors such as Schneiderian membrane perforations, initial implant stability, postoperative sinus infections, smoking, periodontal disease, sinus pathology, and other systemic and behavioral factors.
Studies are warranted to evaluate tissue-engineering techniques (e.g., molecular, cellular, and genetic) that may reduce the time required prior to prosthesis delivery and may enhance bone quality and quantity. These studies ideally should use a bilateral sinus model.
Further studies to evaluate the efficacy of alternative sinus bone augmentation techniques are recommended, due to the limited number of studies on these alternative techniques (e.g., osteotome, localized management of the sinus floor, crestal core elevation).
5. How can the information from the evidence-based review be applied to patient management? A. There is evidence to indicate that the lateral window technique for the sinus bone augmentation procedure is successful at regenerating sufficient bone for implant placement. The implant survival rate is greater than 90%, which is similar to implants placed in native bone.
Level of Evidence:3 Strong. Rationale: Assignment of this level of evidence is based on 3 level I, 4 level 11-1, 11 level 11-2, and 16 level 11-3 studies. These 34 studies included 5,267 implants thus providing a well-founded estimate of the survival rate.
B. There is evidence that the following factors, when adjusted for other variables, increase implant survival when performing lateral wall sinus bone augmentation procedures:
Membrane coverage (93.6% survival) and no membrane coverage (88.7% survival) of the lateral window.
Wallace, Froum
The forest plot (Fig. 1) Particulate bone grafts (92.3% survival) rather than block grafts (83.3% survival). These percentages (least square means) were adjusted for other variables as determined by meta-regression.
Level of Evidence: Moderate. Rationale: Assignment of this level of evidence is based on 3 level I, 4 level 11-1, 10 level 11-2, and 12 levelll-3 studies.
Rough (94.6% survival) surfaces and machined (90.0% survival) surfaces for the implants. These percentages {least square means) were adjusted for other variables as determined by meta-regression.
Level of Evidence: Moderate. Rationale: Assignment of this level of evidence is based on 1 level I, 2 levelll-1, 7 levelll-2, and 12 level 11-3 studies.
C. There is insufficient evidence to support the use of platelet-rich plasma (PRP) in lateral wall sinus bone augmentation.
Level of Evidence: Insufficient. Rationale: Assignment of this level of evidence is based on 1 levelll-3 study, 8 histomorphometric studies, and 1 review.
